Web2 mrt. 2024 · Severity and extent of coronary artery disease (CAD) assessed by invasive coronary angiography (ICA) guide treatment and may predict clinical outcome in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS). Objectives: Web5 okt. 2024 · 1. ประเมินลักษณะของการเจ็บหน้าอกที่เกิดขึ้น ได้แก่ ลักษณะของอาการเจ็บ ตำแหน่งที่เกิด ช่วงเวลา ความเปลี่ยนแปลงที่สังเกตได้ อาการร่วมต่างๆ
Timing and completeness of revascularisation in acute coronary
Web17 feb. 2024 · Mineralocorticoid Receptor Antagonists (MRA) Indications: Need all of: On max dose ACEi, BB, and post-MI + EF ≤ 40% + (HF symptoms or DMII) [Class I] CCS 2024 HF Guideline: “MRA for patients with acute MI with EF < 40% and HF or with acute MI and an EF < 30% alone in the presence of diabetes”. Trial: EPHESUS. WebTo lower the risk of major adverse events, the 2024 guidelines recommend an early routine invasive approach within 24 h for any of the following high-risk criteria: non-ST-segment elevation myocardial infarction (NSTEMI) based on hs-cTn measurements, GRACE risk score >140, and dynamic or presumably new contiguous ST/T-segment changes … scotty 2500 electric line trap and pot puller
治疗策略与时机的选择,你必须明确:2024 ESC NSTE-ACS指南系列解读之五|安贞心语
Web24 dec. 2012 · NSTEACS, High Risk Unstable Angina Pectoris and Non-ST-Elevation Myocardial Infarction Management Plan. Assessment / Investigations Management Rehabilitation / Education • Basic explanation of AMI and UAP, diagnostic procedures, mobilisation and bed. exercises, risk factors and social supports Web27 apr. 2024 · In patients with atrial fibrillation (AF) and NSTE-ACS taking an oral anticoagulant, triple antithrombotic therapy with aspirin, clopidogrel, and a direct oral anticoagulant should be administered for up to 1 week, with de-escalation to dual antithrombic therapy with clopidogrel and a direct oral anticoagulant (class I, level A). scotty 2612